Ukuhlolwa kofuzo kungashintsha ukwelashwa kwalesi sifo esingavamile samathumbu

Yabelana ngalokhu okuthunyelwe

Umdlavuza we-appedic uyivelakancane kakhulu, ubalwa ngaphansi kwe-1% yezimila zamathumbu, futhi kunemininingwane encane yesayensi ngalesi sifo, okusho ukuthi imihlahlandlela yamanje yokwelapha umdlavuza wamathumbu iyanconywa ezigulini ezinomdlavuza we-appendic. Ukuze uqonde ukuthi kungani ezinye iziguli ezinomdlavuza we-appendix zisabela ekwelapheni okujwayelekile komdlavuza wekoloni, kuyilapho abanye bengakwenzi, abacwaningi benze uhlaziyo lofuzo lwamasampula omdlavuza we-appendix angama-703. Lolu wucwaningo olukhulu kakhulu lomdlavuza we-appendix ukuqhathanisa izinguquko ezikhona ezinhlotsheni ezimbili zomdlavuza.

Imiphumela yocwaningo iqinisekise ukuthi ukuguqulwa kofuzo kumdlavuza we-appendix kuhlukile kulokho okukumdlavuza wekoloni. Ukuguqulwa kwe-TP53 kanye ne-GNAS kuyizibikezelo ezinhle zokusinda ezigulini ezinomdlavuza we-appendix. Ngomdlavuza we-appendix ongavamile, ukuthola amamephu wamangqamuzana kuzosiza ukunquma izinketho zokwelapha ezingaba khona ngoba asinayo idatha yesilingo somtholampilo esiqondisa ukwelashwa okujwayelekile njengamanye umdlavuza. Okubaluleke ngokufanayo, i-mutation spectrum ingasetshenziswa njenge-biomarker ukuhlukanisa iziguli ezisengozini enkulu ezidinga ukwelashwa okuqinile ukuze zizihlukanise neziguli ezisengozini encane.

Ucwaningo lwe-retrospective luthole ukuthi umdlavuza we-appendix uhlanganisa izinhlobo ezinhlanu ezihlukene: i-mucinous adenocarcinoma (46%), i-adenocarcinoma (30%), i-goblet cell carcinoma (12%), i-peritoneal pseudomyxoma (7.7%), ne-signet ring Cell carcinoma (5.2%). Ukuguqulwa kofuzo lwe-GNAS okungajwayelekile kumdlavuza wekholoni kuvame kakhulu kumdlavuza we-appendix, ikakhulukazi i-mucinous adenocarcinoma (52%) kanye ne-peritoneal pseudomyxoma (72%). Ukusinda okumaphakathi kweziguli ezinamathumba anokuguqulwa kwe-GNAS cishe iminyaka eyi-10, kuyilapho ukusinda okumaphakathi kweziguli ezinamathumba anokuguqulwa kwe-TP53 iminyaka emithathu kuphela, futhi ukusinda okumaphakathi kweziguli ngaphandle kwalokhu kuguqulwa kofuzo okubili iminyaka engu-6.

Lokhu kutholakala okumangazayo kuphakamisa umbuzo wokuthi ingabe iziguli ezinezimila ze-GNAS-mutant ezisanda kuqala zidinga ukwelashwa ngamakhemikhali ngoba zingelapheka ngokuhlinzwa kuphela, ngakho ucwaningo olwengeziwe luyadingeka ukuze kufakazele lokho.

Bhalisa ku-Newsletter yethu

Thola izibuyekezo futhi ungalokothi uphuthelwe ibhulogi evela kuCancerfax

Okuningi Okuzohlolwa

Iqhaza labezimo eziphuthumayo empumelelweni yokwelashwa kwe-CAR T Cell
Ukwelashwa kwe-CAR T-Cell

Iqhaza labezimo eziphuthumayo empumelelweni yokwelashwa kwe-CAR T Cell

Abezimo eziphuthumayo badlala indima ebalulekile empumelelweni yokwelashwa kwe-CAR T-cell ngokuqinisekisa ukunakekelwa kwesiguli okungenamthungo kuyo yonke inqubo yokwelashwa. Banikeza ukwesekwa okubalulekile ngesikhathi sokuthutha, ukuqapha izimpawu ezibalulekile zeziguli, nokuphatha ukungenelela kwezokwelapha eziphuthumayo uma izinkinga ziphakama. Ukusabela kwabo okusheshayo kanye nokunakekelwa kochwepheshe kunomthelela ekuphepheni okuphelele nasekusebenzeni ngempumelelo kokwelashwa, kusiza uguquko olushelelayo phakathi kwezilungiselelo zokunakekelwa kwezempilo kanye nokwenza ngcono imiphumela yesiguli endaweni eyinselele yezindlela zokwelapha ezithuthukisiwe zamaselula.

Dinga usizo? Ithimba lethu likulungele ukukusiza.

Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton